EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling

Warisara Parichatikanond, Sudhir Pandey, Supachoke Mangmool

Biochemical Pharmacology · 2024

DOI: 10.1016/j.bcp.2024.116552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Pharmacology, 2024. Verfasst von Warisara Parichatikanond und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand. Electronic address: warisara.par@mahidol.ac.th. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor, TOR Serine-Threonine Kinases, Exenatide, Signal Transduction. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Council of Thailand, Chiang Mai University, Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction is associated with hyperglycemic conditions and insulin resistance leading to cellular damage and apoptosis of cardiomyocytes in diabetic cardiomyopathy. The dysregulation of glucagon-like peptide-1 (GLP-1) receptor and mammalian target of rapamycin (mTOR) is linked to cardiomyopathies and myocardial dysfunctions mediated by hyperglycemia. However, the involvements of mTOR for GLP-1 receptor-mediated cardioprotection against high glucose (HG)-induced mitochondrial disturbances are not clearly identified. The present study demonstrated that HG-induced cellular stress and mitochondrial damage resulted in impaired ATP production and oxidative defense markers such as catalase and SOD2, along with a reduction in survival markers such as Bcl-2 and p-Akt, while an increased expression of pro-apoptotic marker Bax was observed in H9c2 cardiomyoblasts. In addition, the autophagic marker LC3-II was considerably reduced, together with the disruption of autophagy regulators (p-mTOR and p-AMPKα) under the hyperglycemic state. Furthermore, there was a dysregulated expression of several indicators related to mitochondrial homeostasis, including MFN2, p-DRP1, FIS1, MCU, UCP3, and Parkin. Remarkably, treatment with either exendin-4 (GLP-1 receptor agonist) or rapamycin (mTOR inhibitor) significantly inhibited HG-induced mitochondrial damage while co-treatment of exendin-4 and rapamycin completely reversed all mitochondrial abnormalities. Antagonism of GLP-1 receptors using exendin-(9-39) abolished these cardioprotective effects of exendin-4 and rapamycin under HG conditions. In addition, exendin-4 attenuated HG-induced phosphorylation of mTOR, and this inhibitory effect was antagonized by exendin-(9-39), indicating the regulation of mTOR by GLP-1 receptor. Therefore, improvement of mitochondrial dysfunction by stimulating the GLP-1 receptor/AMPK/Akt pathway and inhibiting mTOR signaling could ameliorate cardiac abnormalities caused by hyperglycemic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucagon-Like Peptide-1 ReceptorTOR Serine-Threonine KinasesExenatideSignal TransductionGlucoseCardiotonic AgentsGlucagon-Like Peptide-1 Receptor AgonistsAnimalsRatsCell LineMitochondria, HeartMyocytes, CardiacPeptides

Stichwörter der Autor:innen

CardioprotectionExendin-4GLP-1 receptorHigh glucoseMitochondrial dysfunctionmTOR

Substanzen

Glucagon-Like Peptide-1 ReceptorTOR Serine-Threonine KinasesExenatideGlucoseCardiotonic AgentsGlp1r protein, ratmTOR protein, ratPeptidesGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand. Electronic address: warisara.par@mahidol.ac.th.
  • Department of Pharmacology, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand.
  • Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand.

Förderung

  • National Research Council of Thailand
  • Chiang Mai University
  • Mahidol University

Zitieren

APA

Parichatikanond, W., Pandey, S., & Mangmool, S. (2024). Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling. Biochemical Pharmacology. https://doi.org/10.1016/j.bcp.2024.116552

Vancouver

Parichatikanond W, Pandey S, Mangmool S. Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling. Biochemical Pharmacology. 2024. doi:10.1016/j.bcp.2024.116552

BibTeX
@article{Parichatikanond2024,
  author = {Parichatikanond, Warisara and Pandey, Sudhir and Mangmool, Supachoke},
  title = {Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: Potential role of GLP-1 receptor and mTOR signaling},
  journal = {Biochemical Pharmacology},
  year = {2024},
  doi = {10.1016/j.bcp.2024.116552}
}
Kostenlos starten →